# Rehmannia glutinosa polysaccharides: a review on structural features, pharmacological potential, and advanced delivery systems

**Authors:** Bo Wang, Xin Ma, Xia Yang, Jie Yang, Xuebing Zhou, Xiaoling Ding

PMC · DOI: 10.3389/fnut.2026.1772902 · Frontiers in Nutrition · 2026-03-18

## TL;DR

This review explores Rehmannia glutinosa polysaccharides, highlighting their health benefits and challenges in developing them into effective medicines.

## Contribution

The paper provides a comprehensive overview of RGPs' structure, bioactivities, and delivery systems, identifying key barriers and future directions.

## Key findings

- RGPs have diverse bioactivities like immunomodulation and anti-tumor effects.
- Green extraction methods improve bioactivity preservation and yield.
- Nano-delivery systems enhance solubility and targeted delivery of RGPs.

## Abstract

Rehmannia glutinosa polysaccharides (RGPs) are recognized for their diverse pharmacological potential. However, their translation into practical applications faces significant hurdles. The primary challenges include their intrinsic structural complexity, poor oral bioavailability, and poorly defined structure–activity relationships (SAR). This review highlights that RGPs, as complex heteropolysaccharides, exhibit diverse bioactivities including immunomodulation, anti-inflammatory, antitumor, anti-aging, and metabolic regulation. Innovative green extraction techniques enhance yield and preserve bioactivity compared to conventional methods. Structural analyses reveal that molecular weight (MW), monosaccharide composition, and glycosidic linkages critically influence functions. Chemical modifications and nano-delivery systems improve solubility, bioavailability, and targeted delivery. Pharmacological studies show RGPs modulate gut microbiota, increasing short-chain fatty acid production, which mediates systemic benefits. However, clinical application requires addressing batch variability, scalability, and the lack of human trials. Future research should focus on precise structural elucidation, quantitative structure–activity models, and smart formulations to advance RGPs as therapeutics and functional foods in precision medicine.

## Linked entities

- **Species:** Rehmannia glutinosa (taxon 99300)

## Full-text entities

- **Diseases:** inflammatory (MESH:D007249)
- **Chemicals:** RGPs (-), monosaccharide (MESH:D009005), short-chain fatty acid (MESH:D005232)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC13038584/full.md

## Figures

3 figures with captions in the complete paper: https://tomesphere.com/paper/PMC13038584/full.md

## References

117 references — full list in the complete paper: https://tomesphere.com/paper/PMC13038584/full.md

---
Source: https://tomesphere.com/paper/PMC13038584